Our magazine is free!

for living with diabetes

Articles related to "GSK" »

GSK’s new T1 drug fails phase III clinical trial

Wednesday, March 30th, 2011 | 0 Comments
GlaxoSmithKline says that Otelixizumab, a Type 1 drug currently under development, has failed in a phase III clinical trial. The drug has been in development in partnership with Tolerx, according to a recent article from Reuters. The drug was designed for people with read more »
""

nl-imageDirect to your inbox, our

free online magazine.

Sign up for the Desang Diabetes Magazine for new products, special offers and news.

*We will never email you more often than once a week (usually once a month). You can easily unsubscribe at any time. It’s finger-pricking good!

Close Don't show again